(Q46664921)

English

Effects of cilostazol and pentoxifylline on forearm reactive hyperemia response, lipid profile, oxidative stress, and inflammatory markers in patients with intermittent claudication.

scientific article published on 2 April 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18388031%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Effects of cilostazol and pentoxifylline on forearm reactive hyperemia response, lipid profile, oxidative stress, and inflammatory markers in patients with intermittent claudication (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18388031%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Carlos Eduardo Virgini-Magalhães

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18388031%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

author name string

Renato Maranhão de Albuquerque

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18388031%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Fernando Lencastre Sicuro

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18388031%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Daniel Alexandre Bottino

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18388031%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Eliete Bouskela

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18388031%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

publication date

2 April 2008

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18388031%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18388031%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

59

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18388031%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18388031%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

549-558

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18388031%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000.

1 reference

https://api.crossref.org/works/10.1177%2F0003319707309656

21 January 2018

Medical treatment of peripheral arterial disease

1 reference

https://api.crossref.org/works/10.1177%2F0003319707309656

21 January 2018

Intermittent claudication: magnitude of the problem, patient evaluation, and therapeutic strategies

1 reference

https://api.crossref.org/works/10.1177%2F0003319707309656

21 January 2018

Effect on platelet function of cilostazol, clopidogrel, and aspirin, each alone or in combination

1 reference

https://api.crossref.org/works/10.1177%2F0003319707309656

21 January 2018

The US experience with cilostazol in treating intermittent claudication

1 reference

https://api.crossref.org/works/10.1177%2F0003319707309656

21 January 2018

Medical treatment of peripheral arterial disease and claudication

1 reference

https://api.crossref.org/works/10.1177%2F0003319707309656

21 January 2018

Treatment of intermittent claudication with physical training, smoking cessation, pentoxifylline, or nafronyl: a meta-analysis

1 reference

https://api.crossref.org/works/10.1177%2F0003319707309656

21 January 2018

Evaluating endothelial function in humans: a guide to invasive and non-invasive techniques

1 reference

https://api.crossref.org/works/10.1177%2F0003319707309656

21 January 2018

Molecular pharmacology of isoprostanes in vascular smooth muscle

1 reference

https://api.crossref.org/works/10.1177%2F0003319707309656

21 January 2018

Flow-mediated dilatation in human circulation: diagnostic and therapeutic aspects.

1 reference

https://api.crossref.org/works/10.1177%2F0003319707309656

21 January 2018

Effect of ascorbic acid on forearm reactive hyperaemia in patients with hypercholesterolaemia

1 reference

https://api.crossref.org/works/10.1177%2F0003319707309656

21 January 2018

Fluvastatin improves endothelial dysfunction in overweight postmenopausal women through small dense low-density lipoprotein reduction

1 reference

https://api.crossref.org/works/10.1177%2F0003319707309656

21 January 2018

Simvastatin preserves coronary endothelial function in hypercholesterolemia in the absence of lipid lowering

1 reference

https://api.crossref.org/works/10.1177%2F0003319707309656

21 January 2018

Sildenafil and endothelial dysfunction in humans

1 reference

https://api.crossref.org/works/10.1177%2F0003319707309656

21 January 2018

Acute smoking induces endothelial dysfunction in healthy smokers. Is this reversible by red wine's antioxidant constituents?

1 reference

https://api.crossref.org/works/10.1177%2F0003319707309656

21 January 2018

Endothelium-dependent relaxation by cilostazol, a phosphodiesteras III inhibitor, on rat thoracic aorta

1 reference

https://api.crossref.org/works/10.1177%2F0003319707309656

21 January 2018

Effect of cilostazol on vasomotor reactivity in patients with vasospastic angina pectoris

1 reference

https://api.crossref.org/works/10.1177%2F0003319707309656

21 January 2018

Lack of antiapoptotic effects of antiplatelet drug, aspirin and clopidogrel, and antioxidant, MCI-186, against focal ischemic brain damage in rats

1 reference

https://api.crossref.org/works/10.1177%2F0003319707309656

21 January 2018

Coronary stent restenosis in patients treated with cilostazol

1 reference

https://api.crossref.org/works/10.1177%2F0003319707309656

21 January 2018

Cilostazol improves endothelium-derived hyperpolarizing factor-type relaxation in mesenteric arteries from diabetic rats

1 reference

https://api.crossref.org/works/10.1177%2F0003319707309656

21 January 2018

Pentoxifylline efficacy in the treatment of intermittent claudication: multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patients

1 reference

https://api.crossref.org/works/10.1177%2F0003319707309656

21 January 2018

Medical management of peripheral arterial disease

1 reference

https://api.crossref.org/works/10.1177%2F0003319707309656

21 January 2018

Failure of pentoxifylline or cilostazol to improve blood and plasma viscosity, fibrinogen, and erythrocyte deformability in claudication

1 reference

https://api.crossref.org/works/10.1177%2F0003319707309656

21 January 2018

The effect of chronic tobacco smoking on arterial stiffness

1 reference

https://api.crossref.org/works/10.1177%2F0003319707309656

21 January 2018

Effect of cigarette smoking on nitric oxide, structural, and mechanical properties of mouse arteries.

1 reference

https://api.crossref.org/works/10.1177%2F0003319707309656

21 January 2018

Cilostazol, a potent phosphodiesterase type III inhibitor, selectively increases antiatherogenic high-density lipoprotein subclass LpA-I and improves postprandial lipemia in patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1177%2F0003319707309656

21 January 2018

Reduction of remnant lipoprotein cholesterol concentrations by cilostazol in patients with intermittent claudication

1 reference

https://api.crossref.org/works/10.1177%2F0003319707309656

21 January 2018

Differential lipogenic effects of cilostazol and pentoxifylline in patients with intermittent claudication: potential role for interleukin-6.

1 reference

https://api.crossref.org/works/10.1177%2F0003319707309656

21 January 2018

Endothelial and antithrombotic actions of HDL.

1 reference

https://api.crossref.org/works/10.1177%2F0003319707309656

21 January 2018

Cilostazol inhibits high glucose-mediated endothelial-neutrophil adhesion by decreasing adhesion molecule expression via NO production

1 reference

https://api.crossref.org/works/10.1177%2F0003319707309656

21 January 2018

Vascular biology of the isoprostanes

1 reference

https://api.crossref.org/works/10.1177%2F0003319707309656

21 January 2018

Identifiers

10.1177/0003319707309656

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18388031%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18388031%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46664921&oldid=1962134491"